Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by stockmonster6on Mar 12, 2021 7:15am
150 Views
Post# 32783335

RE:RE:RE:Read between the lines....

RE:RE:RE:Read between the lines....NRV - my read of the NR, is that they have completed the 100 tests, which then they earlier reported that this is when the final design/ science would be 'locked in'.  Now, people they are going to experiment on human live subjects, they need ethical approval.  This approval shouldn't take long, as it is not evasive, nor are they using a concept of deception to determine results.  They aren't using a live control group either; since the 300 persons will be those likely already identified as Covid positive.  The AcuVid then will be used to see if it receives the same results.

This study of the 300 pers, is the required study for Health Canada approval.
When I read HC's website, they set the scope of what they require for submissions; which THRM is following.  Once this study is completed, they can apply to HC for their approval.

HC may take 45 days to approve applications; maybe quicker due to Covid fast tracks.  

The timeline is getting nearer.  My best estimate would be potentially mid May to receive back HC approval (could be early or late May, but I'm going to stick with mid May).

During this time before now and then, they will be already lining up manufacturers as previously detailed in the other NRs.  Now their design is "locked in" they are obviously happy with its performance and results.  A manufacturer will be being sourced to design it to their specs.

Production could commence as soon as HC approval is given, should THRM get their ducks in a row as I am predicting.  Thus far, they have proven competent in this regard.

Good luck everyone!  The THRM Tsunami is coming!
<< Previous
Bullboard Posts
Next >>